| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $13.4M | +38.3% |
| SG&A Expense | $5.8M | -3.1% |
| Operating Income | -$28.0M | -78.7% |
| Pre-tax Income | -$34.4M | -105.5% |
| Income Tax | $226K | — |
| Net Income | -$34.7M | -106.9% |
| EPS (Basic) | -$52.59 | -11.6% |
| EPS (Diluted) | -$52.59 | -11.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.8M | +206.5% |
| Current Assets | $22.0M | +209.9% |
| Total Assets | $162.4M | +2126.3% |
| Current Liabilities | $3.5M | +26.1% |
| Total Liabilities | $10.5M | +12.9% |
| Stockholders' Equity | $10.3M | +612.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.5M | -46.3% |
| Capital Expenditures | $7K | -69.4% |
| Investing Cash Flow | -$4K | +79.6% |
| Financing Cash Flow | $31.5M | +92.2% |
| Free Cash Flow | -$19.5M | -46.2% |